• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.78% Nasdaq Down 1.13%

    ACADIA Pharmaceuticals Inc. (ACAD)

    -NasdaqGS
    30.00 Down 3.00(9.09%) 4:00PM EDT
    |After Hours : 29.75 Down 0.25 (0.83%) 6:58PM EDT - Nasdaq Real Time Price
    Prev Close:33.00
    Open:31.81
    Bid:29.75 x 500
    Ask:29.85 x 100
    1y Target Est:46.10
    Beta:3.6401
    Next Earnings Date: 5-May-16ACAD Earnings announcement
    Day's Range:29.75 - 32.21
    52wk Range:16.64 - 51.99
    Volume:4,296,849
    Avg Vol (3m):3,169,270
    Market Cap:3.38B
    P/E (ttm):N/A
    EPS (ttm):-1.63
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    ACADDown 9.09%3.38B
    AZNDown 1.23%73.11B
    PFEUp 2.74%208.67B
    LLYDown 0.65%81.06B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):54,753.49
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.45
    Quarterly EPS Est (Mar-16) :-0.42
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-0.31

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback